Not Signed In -
Multiple endocrine neoplasia type 2 |
MEN 2; MEN II |
Multiple endocrine neoplasia type 2 is part of a group of disorders that affect the endocrine system. These disorders greatly increase the risk of developing multiple cancerous and noncancerous tumors in glands such as the thyroid, parathyroid, and adrenals. Multiple endocrine neoplasia occurs when tumors are found in at least two endocrine glands. Tumors can also develop in organs and tissues other than endocrine glands. If the tumors become cancerous, some cases can be life-threatening. Th ...
Wikipedia - [full article]
Multiple endocrine neoplasia type 2 Clinical Trials
- Studies of Inherited Diseases of Metabolism
ClinicalTrials.gov Identifier: NCT00001345 - Recruiting
Hypercalcemia; Hyperparathyroidism; Multiple Endocrine Neoplasia
- Psychosocial Aspects of MEN Syndromes
ClinicalTrials.gov Identifier: NCT00501449 - Recruiting
Multiple Endocrine Neoplasia
- Vandetanib in Treating Young Patients With Medullary Thyroid Cancer
ClinicalTrials.gov Identifier: NCT00514046 - Recruiting
Head and Neck Cancer; Multiple Endocrine Neoplasia 1 and 2 (men1, men2)
- Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer
ClinicalTrials.gov Identifier: NCT00390325 - Recruiting
Head and Neck Cancer; Multiple Endocrine Neoplasia 1 and 2 (men1, men2)
- Genetic Study of Patients With Inherited Urologic Malignancies
ClinicalTrials.gov Identifier: NCT00019617 - Recruiting
Birt Hogg Dube Syndrome; Kidney Cancer; Multiple Endocrine Neoplasia 1 and 2 (men1, men2); Von Hippel-Lindau Syndrome
- Pazopanib in Treating Patients With Advanced Neuroendocrine Cancer
ClinicalTrials.gov Identifier: NCT00454363 - Recruiting
Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Lung Cancer; Multiple Endocrine Neoplasia 1 and 2 (men1, men2); Neoplastic Syndrome
- Treatment of Zollinger-Ellison Syndrome With Prevacid
ClinicalTrials.gov Identifier: NCT00204373 - Recruiting
Zollinger-Ellison Syndrome; Multiple Endocrine Neoplasia
- Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00098475 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Dexamethasone With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00064038 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Prostate Cancer Prevention Study for Men with High Grade PIN (Prostatic Intraepithelial Neoplasia)
ClinicalTrials.gov Identifier: NCT00106691 - Active, not recruiting
Preneoplastic Conditions; Prostatic Intraepithelial Neoplasia
- Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00003603 - Active, not recruiting
refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Thalidomide and Prednisone After Autologous Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00049673 - Recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Colorectal Neoplasia Screening With Colonoscopy in Asymptomatic Women at Regional Navy/Army Medical Centers: The CONCeRN Trial
ClinicalTrials.gov Identifier: NCT00339950 - Active, not recruiting
Colorectal Neoplasia
- Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma, DCIS or ADH in Patients with Lobular Neoplasia of the Breast
ClinicalTrials.gov Identifier: NCT00146536 - Recruiting
Lobular neoplasia of the breast
- Endocrine Studies in Health and Disease
ClinicalTrials.gov Identifier: NCT00006073 - Recruiting
Endocrine Diseases
- A Pilot Study of Lycopene Supplementation in Prostatic Intraepithelial Neoplasia
ClinicalTrials.gov Identifier: NCT00178113 - Active, not recruiting
Prostatic Intraepithelial Neoplasia
- Evaluation of Women with Endocrine and Reproductive-Related Conditions
ClinicalTrials.gov Identifier: NCT00001850 - Recruiting
Endocrine Disease; Infertility
- Evaluation of Patients with Endocrine-Related Conditions
ClinicalTrials.gov Identifier: NCT00005664 - Recruiting
Endocrine Disease; Glucose Intolerance; Hyperinsulinemia; Impaired Glucose Tolerance; Non Insulin Dependent Diabetes Mellitus; Obesity; ...
- Study of Lanreotide Autogel in Non-Functioning Entero-Pancreatic Endocrine Tumours
ClinicalTrials.gov Identifier: NCT00353496 - Recruiting
Endocrine Tumors
- Vaccine Therapy Plus GM-CSF in Treating Patients With Multiple Myeloma Undergoing Bone Marrow or Peripheral Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00002787 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Randomized Controlled Trial on Radiotherapy +/- Endocrine Therapy for PSA Failure After Radical Prostatectomy (JCOG0401)
ClinicalTrials.gov Identifier: NCT00138008 - Recruiting
Prostate Cancer
- A Multiple Dose Drug Study of MK0941 in Patients With Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00511667 - Recruiting
Type 2 Diabetes Mellitus
- Safety Study to Test the Safety of HspE7 and Poly-ICLC Given in Patients With Cervical Intraepithelial Neoplasia
ClinicalTrials.gov Identifier: NCT00493545 - Recruiting
Cervical Intraepithelial Neoplasia
- Molecular Imaging for Detection of Cervical Intraepithelial Neoplasia
ClinicalTrials.gov Identifier: NCT00511615 - Recruiting
Cervical Intraepithelial Neoplasia
- Tandem Autologous Stem Cell Transplantation With or Without Maintenance Therapy After the Second Transplantation Compared With Autologous Stem Cell Transplantation Followed By Matched Sibling Allogeneic Stem Cell Transplantation in Patients With Stage II
ClinicalTrials.gov Identifier: NCT00075829 - Active, not recruiting
stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- A Study to Evaluate Rituximab in Adults with Relapsing Remitting Multiple Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00097188 - Active, not recruiting
Multiple Sclerosis
- Bortezomib and Liposomal Doxorubicin in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00088855 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Combination Chemotherapy and Interferon alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma
ClinicalTrials.gov Identifier: NCT00002599 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus.
ClinicalTrials.gov Identifier: NCT00517465 - Recruiting
Diabetes Mellitus, Type 2
- Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00004903 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Bortezomib in Combination with CC-5013 in Patients with Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00153933 - Active, not recruiting
Refractory Multiple Myeloma; Relapsed Multiple Myeloma; Multiple Myeloma
- PS-341 in Treating Patients With Refractory or Progressive Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00049478 - Active, not recruiting
refractory plasma cell neoplasm
- Combination Chemotherapy With or Without Interferon alfa in Treating Patients With Previously Untreated Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00002556 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00003490 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Combination Chemotherapy in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00002678 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- BEYOND Study - Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
ClinicalTrials.gov Identifier: NCT00099502 - Active, not recruiting
Multiple Sclerosis
- A Chemoprevention Study of an Investigational Drug in Men with High Grade Prostate Intraepithelial Neoplasia (PIN)
ClinicalTrials.gov Identifier: NCT00028353 - Completed
Prostatic Intraepithelial Neoplasia
- Post-Marketing Safety Study of GSK Biological''s Pediarix™ Vaccine.
ClinicalTrials.gov Identifier: NCT00146835 - Active, not recruiting
Prophylaxis: Diphtheria, tetanus, pertussis, hepatitis B, poliovirus type 1, type 2 and type 3
- Melphalan, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00003954 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Gynecologic Malignancy
ClinicalTrials.gov Identifier: NCT00058071 - Active, not recruiting
Endocrine Cancer; female reproductive cancer; neurotoxicity
- Safety of RG2077 in Patients With Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00076934 - Active, not recruiting
Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting
- Combination Chemotherapy With or Without Thalidomide in Treating Patients With Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00005834 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Safety, Tolerability, and Effect of LY2405319 After Multiple Injections in Subjects With Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00481117 - Not yet recruiting
Type 2 Diabetes
- Phase III Randomized Study of Melphalan With or Without Holmium Ho 166 DOTMP Followed By Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00008229 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Efficacy and Safety In Poorly Controlled Type 2 Diabetics
ClinicalTrials.gov Identifier: NCT00044460 - Active, not recruiting
type 2 diabetes
- Rebif® New Formulation in Relapsing Forms of Multiple Sclerosis (RMS)
ClinicalTrials.gov Identifier: NCT00110396 - Active, not recruiting
Multiple Sclerosis
- Combination Therapy with Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00037102 - Active, not recruiting
Multiple Sclerosis
- T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant
ClinicalTrials.gov Identifier: NCT00048464 - Active, not recruiting
Multiple Myeloma
- Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00017602 - Active, not recruiting
refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00124579 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy
ClinicalTrials.gov Identifier: NCT00084370 - Active, not recruiting
ovarian epithelial cancer
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00005792 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Repeat-Dose Pharmacokinetics and Pharmacodynamics of Bortezomib in Patients with Relapsed Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00080405 - Active, not recruiting
Multiple Myeloma
- Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00040937 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes
ClinicalTrials.gov Identifier: NCT00229658 - Active, not recruiting
Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus
- Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00006219 - Active, not recruiting
Multiple Myeloma
- Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00006890 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00014508 - Active, not recruiting
refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Extension Study of the Efficacy and Safety of Oral SCIO-469 in Relapsed, Refractory Patients with Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00095680 - Active, not recruiting
Multiple Myeloma
- A Study to Evaluate the Safety and Efficacy of Rituximab in Adults with Primary Progressive Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00087529 - Active, not recruiting
Multiple Sclerosis
- Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00049374 - Active, not recruiting
refractory plasma cell neoplasm
- High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse
ClinicalTrials.gov Identifier: NCT00002630 - Active, not recruiting
stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Safety and efficacy of single-agent CC-5013 in subjects with relapsed and refractory multiple myeloma
ClinicalTrials.gov Identifier: NCT00065351 - Active, not recruiting
Multiple Myeloma
- Colorectal Cancer Screening Intervention in UWPN Clinics
ClinicalTrials.gov Identifier: NCT00161460 - Recruiting
Colorectal neoplasia
- Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
ClinicalTrials.gov Identifier: NCT00002850 - Recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; Infection
- Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003653 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- VELCADE/Melphalan/Prednisone Versus Melphalan/Prednisone in Patients with Previously Untreated Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00111319 - Active, not recruiting
Multiple Myeloma
- Chemotherapy, Vaccine Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00024466 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Auditory Function in Patients With and Without Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00037947 - Recruiting
Multiple Sclerosis
- Immunotherapy with BHT-3009 Alone or Combined with Atorvastatin in Patients with Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00103974 - Active, not recruiting
Multiple Sclerosis
- Study of Oral SCIO-469 in Relapsed, Refractory Patients with Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00087867 - Active, not recruiting
Multiple Myeloma
- Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00004158 - Active, not recruiting
stage II multiple myeloma; stage III multiple myeloma; stage I multiple myeloma; refractory plasma cell neoplasm
- Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00021359 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00002653 - Active, not recruiting
Multiple Myeloma
- Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00004165 - Active, not recruiting
refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; primary systemic amyloidosis
- Evaluation of Safety and Immunogenicity of Co-Administering HPV Vaccine With Other Vaccines in Healthy Female Subjects
ClinicalTrials.gov Identifier: NCT00426361 - Active, not recruiting
Papillomavirus Infections; Cervical Neoplasia
- Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Previously Untreated Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00002548 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- UARK 2003-25: A Study of Intravenous (IV) Busulfan (Busulfex®) in Multiple Myeloma Patients
ClinicalTrials.gov Identifier: NCT00113919 - Active, not recruiting
Multiple Myeloma
- Thal/Dex (Thalidomide and Dexamethasone) vs. Dd-T (Doxil, Dexamethasone and Thalidomide) in Multiple Myeloma Patients
ClinicalTrials.gov Identifier: NCT00097981 - Active, not recruiting
Multiple Myeloma
- Combination Chemotherapy, Peripheral Stem Cell Transplantation, Biological Therapy, Pamidronate and Thalidomide in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00004088 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- R115777 in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00021203 - Active, not recruiting
stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Melphalan and Prednisone With or Without Bortezomib in Treating Older Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00109902 - Recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- SPECT/CT in Endocrine and Neuroendocrine Tumors
ClinicalTrials.gov Identifier: NCT00230139 - Recruiting
Endocrine and Neuroendocrine Tumors
- Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon alfa in Treating Patients With Advanced Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00006244 - Active, not recruiting
refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Study of Combination Thalidomide Plus Glucocorticoid Therapy Versus Glucocorticoid Therapy Alone as Induction Therapy for Previously Untreated Subjects with Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00057564 - Active, not recruiting
Multiple Myeloma
- Long-Term Study of Safety and Efficacy of WelChol® as an Additional Therapy in Patients with Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00151762 - Active, not recruiting
Type 2 Diabetes
- Measurement of Digital Colposcopy for Fluorescence Spectroscopy of Cervical Intraepithelial Neoplasia
ClinicalTrials.gov Identifier: NCT00513123 - Active, not recruiting
Cervical Cancer
- Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00045136 - Active, not recruiting
refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00411723 - Recruiting
Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting
- Bortezomib in Treating Patients With Newly Diagnosed High-Risk Stage III Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00075881 - Active, not recruiting
stage III multiple myeloma
- Islet Transplantation in Type 1 Diabetics Using the Edmonton Protocol of Steroid Free Immunosuppression
ClinicalTrials.gov Identifier: NCT00133809 - Active, not recruiting
Diabetes Mellitus, Type 1
- CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects with Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00056160 - Active, not recruiting
Multiple Myeloma
- Study of DOXIL/CAELYX and VELCADE or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00103506 - Active, not recruiting
Multiple Myeloma
- Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00151203 - Active, not recruiting
Multiple Myeloma
- EARLY IFNb-1a and Atorvastatin Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00137176 - Recruiting
Multiple Sclerosis
- EARLY IFNB-1a and Simvastatin Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00146068 - Recruiting
Multiple Sclerosis
- Multiple Grain in Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00337337 - Recruiting
Diabetes Mellitus
- Study to Compare the Efficacy of the MiniMed Paradigm REAL-Time System Vs. Multiple Daily Injections in Subjects Naive to Insulin Pump Therapy
ClinicalTrials.gov Identifier: NCT00417989 - Recruiting
Type 1 Diabetes
- Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients
ClinicalTrials.gov Identifier: NCT00220493 - Recruiting
Relapsing Remitting Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive
- Efficacy and Safety of Fingolimod in Patients With Relapsing-Remitting Multiple Sclerosis With Optional Extension Phase
ClinicalTrials.gov Identifier: NCT00340834 - Active, not recruiting
Multiple Sclerosis
Resources
- Multiple endocrine neoplasia type 2 (Genetics Home Reference)
email this page
print this page
bookmark this page
feedback on this page
